Other

Thereafter

Moderna Thereafter decreased by 10.7% to $679.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.3%, from $757.00M to $679.00M.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2021
Last reportedQ1 2026May 1, 2026
Metric ID: other_lessee_operating_lease_liability_to_be_paid_after__c7b883

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$94.00M$94.00M$51.00M$51.00M$51.00M$48.00M$48.00M$869.00M$784.00M$833.00M$841.00M$757.00M$762.00M$760.00M$679.00M
QoQ Change+0.0%-45.7%+0.0%+0.0%-5.9%+0.0%>999%-9.8%+6.3%+1.0%-10.0%+0.7%-0.3%-10.7%
YoY Change-45.7%-45.7%-5.9%-5.9%>999%>999%>999%-3.2%-3.4%-8.5%-9.6%-10.3%
Range$48.00M$869.00M
CAGR+75.9%
Avg YoY Growth+386.2%
Median YoY Growth-5.9%
Current Streak2 quarters decline

Frequently Asked Questions

What is Moderna's thereafter?
Moderna (MRNA) reported thereafter of $679.00M in Q1 2026.
How has Moderna's thereafter changed year-over-year?
Moderna's thereafter decreased by 10.3% year-over-year, from $757.00M to $679.00M.